KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cvs Health (CVS) Other financing activities (2016 - 2025)

Historic Other financing activities for Cvs Health (CVS) over the last 17 years, with Q4 2025 value amounting to $7.0 million.

  • Cvs Health's Other financing activities fell 8541.67% to $7.0 million in Q4 2025 from the same period last year, while for Sep 2025 it was $41.0 million, marking a year-over-year increase of 41538.46%. This contributed to the annual value of $26.0 million for FY2024, which is 11293.53% up from last year.
  • Per Cvs Health's latest filing, its Other financing activities stood at $7.0 million for Q4 2025, which was down 8541.67% from $38.0 million recorded in Q3 2025.
  • Cvs Health's Other financing activities' 5-year high stood at $75.0 million during Q4 2021, with a 5-year trough of -$149.0 million in Q1 2022.
  • Moreover, its 5-year median value for Other financing activities was $7.5 million (2023), whereas its average is -$5.0 million.
  • As far as peak fluctuations go, Cvs Health's Other financing activities skyrocketed by 157500.0% in 2021, and later plummeted by 83333.33% in 2025.
  • Quarter analysis of 5 years shows Cvs Health's Other financing activities stood at $75.0 million in 2021, then tumbled by 46.67% to $40.0 million in 2022, then crashed by 77.5% to $9.0 million in 2023, then surged by 433.33% to $48.0 million in 2024, then crashed by 85.42% to $7.0 million in 2025.
  • Its last three reported values are $7.0 million in Q4 2025, $38.0 million for Q3 2025, and -$22.0 million during Q2 2025.